Related Experiment Video
Updated: Jun 18, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
The many faces of dementia.
1University of New Mexico in Albuquerque, New Mexico.
Radiologic Technology
|November 11, 2009
Summary
Functional medical imaging shows promise as a tool for early dementia detection and management. It may also aid in developing new treatments for Alzheimer disease and other dementias.
Area of Science:
- Neurology
- Medical Imaging
- Geriatrics
Background:
- Dementia is a progressive, incurable neurological condition impacting many individuals.
- Alzheimer disease, vascular dementia, frontotemporal dementia, and dementia with Lewy bodies are key types.
- Aging is the primary risk factor, with significant social and economic consequences.
Purpose of the Study:
- To explore the role of functional medical imaging in dementia.
- To highlight its potential as a screening and diagnostic tool.
- To discuss its application in therapeutic research for dementia and Alzheimer disease.
Main Methods:
- Review of current research on functional medical imaging techniques in dementia.
- Analysis of imaging's utility in early detection and clinical management.
- Examination of imaging's role in drug development for neurodegenerative diseases.
Main Results:
- Functional medical imaging is a valuable research tool for dementia.
- It holds potential for early-stage dementia screening and diagnosis confirmation.
- Imaging aids in patient care management and medication development research.
Conclusions:
- Functional medical imaging is crucial for advancing dementia research.
- Its application may lead to earlier diagnosis and improved patient care.
- Imaging is instrumental in the quest for new dementia and Alzheimer disease therapies.
More Related Videos
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...